136
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Insights from Monitoring Aspirin Adherence: A Medication Adherence Cascade Tool

, , , &
Pages 1639-1646 | Published online: 26 Jul 2021

References

  • Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar‐Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta‐analysis of controlled trials. J Am Heart Assoc. 2016;5(6). doi:10.1161/jaha.115.002606
  • Wu J-R, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43(1):133–153. doi:10.1016/j.cnur.2007.10.006
  • Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782–1787. doi:10.2105/ajph.94.10.1782
  • Dunlay SM, Eveleth JM, Shah ND, Mcnallan SM, Roger VL. Medication adherence among community-dwelling patients with heart failure. Mayo Clin Proc. 2011;86(4):273–281. doi:10.4065/mcp.2010.0732
  • Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23. doi:10.1016/j.amjopharm.2011.02.004
  • Koh JJK, Cheng RX, Yap Y, et al. Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study. Patient Prefer Adherence. 2018;12:2481–2498. doi:10.2147/ppa.s176256
  • Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006;151(1):185–191. doi:10.1016/j.ahj.2005.02.038
  • Osborn CY, Kripalani S, Goggins KM, Wallston KA. Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients. J Health Care Poor Underserved. 2017;28(1):499–513. doi:10.1353/hpu.2017.0036
  • Wu J-R, Lennie TA, Chung ML, et al. Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure. Heart Lung. 2012;41(2):107–114. doi:10.1016/j.hrtlng.2011.09.009
  • Dolansky MA, Hawkins MA, Schaefer JT, et al. Association between poorer cognitive function and reduced objectively monitored medication adherence in patients with heart failure. Circ Heart Fail. 2016;9(12). doi:10.1161/circheartfailure.116.002475
  • Gathright EC, Dolansky MA, Gunstad J, et al. The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure. Health Psychol. 2017;36(9):839–847. doi:10.1037/hea0000529
  • Hawkins LA, Kilian S, Firek A, Kashner TM, Firek CJ, Silvet H. Cognitive impairment and medication adherence in outpatients with heart failure. Heart Lung. 2012;41(6):572–582. doi:10.1016/j.hrtlng.2012.06.001
  • Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424. doi:10.1016/j.ahj.2011.06.007
  • Cullen G, Kelly E, Murray FE. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006;62(2):232–236. doi:10.1111/j.1365-2125.2006.02642.x
  • Widespread aspirin use despite few benefits, high risks. ScienceDaily; July 22, 2019. Available from: https://www.sciencedaily.com/releases/2019/07/190722182126.htm. Accessed July 28, 2020.
  • Monane M. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance results from a population-based study in the elderly. Am J Hypertens. 1997;10(7):697–704. doi:10.1016/s0895-7061(97)00056-3
  • Rieckmann N, Kronish IM, Haas D, et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J. 2006;152(5):922–927. doi:10.1016/j.ahj.2006.05.014
  • Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887. doi:10.1016/j.amjmed.2011.12.013
  • Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH. The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med. 2013;126(4):357.e7–357.e27. doi:10.1016/j.amjmed.2012.09.004
  • Schwartz JK. Pillbox use, satisfaction, and effectiveness among persons with chronic health conditions. Assist Technol. 2016;29(4):181–187. doi:10.1080/10400435.2016.1219884
  • Arnet I, Rothen J-P, Albert V, Hersberger K. Validation of a novel electronic device for medication adherence monitoring of ambulatory patients. Pharmacy. 2019;7(4):155. doi:10.3390/pharmacy7040155
  • Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure. Ann Intern Med. 2007;146(10):714. doi:10.7326/0003-4819-146-10-200705150-00005
  • Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657–665. doi:10.1093/ajhp/60.7.657
  • Cho MH, Shin DW, Chang S-A, et al. Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Sci Rep. 2018;8(1). doi:10.1038/s41598-018-29974-7
  • Gathright EC, Dolansky MA, Gunstad J, Josephson RA, Moore SM, Hughes JW. Examination of attention, executive function, and memory as predictors of mortality risk in adults with systolic heart failure. Eur J Cardiovasc Nurs. 2019;18(8):729–735. doi:10.1177/1474515119863182
  • Stentzel U, van den Berg N, Schulze LN, et al. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry. 2018;18(1). doi:10.1186/s12888-018-1737-4